Cushman & Wakefield (CWK) Stock

I maintain a Hold rating on Cushman & Wakefield stock after analyzing its third quarter financial results and its progress relating to deleveraging. The company's Q3 2024 EPS was boosted by non-operating items such as lower interest expenses. Cushman & Wakefield's normalized EBITDA declined by 5.0% YoY in Q3, which is roughly the same as the company's -4.9% YoY EBITDA decline for Q2.

Cushman & Wakefield (CWK) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.21 per share a year ago.

Cushman & Wakefield (CWK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cushman & Wakefield (CWK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

CHICAGO--(BUSINESS WIRE)-- #cre--Cushman & Wakefield (NYSE: CWK) announced that it has successfully completed a repricing of approximately $1.0 billion of its Term Loan issued in April 2024 due 2030 (“Term Loan”). The repricing reduces the applicable interest rate on the Term Loan by 50 basis points from Term SOFR plus 3.75% to Term SOFR plus 3.25%. There are no changes to the maturity of the Term Loan following this repricing and all other terms are substantially unchanged. Additionally, on Octob.

CHICAGO--(BUSINESS WIRE)-- #cre--Cushman & Wakefield (NYSE: CWK) will release its third quarter 2024 financial results after the close of trading at 4:05 p.m. ET on Monday, November 4, 2024. Management will host a conference call following the release at 5:00 p.m. ET on Monday, November 4, 2024, to discuss the financial results. The conference call can be accessed as follows: Dial in to 1-844-825-9789 (domestic) or 1-412-317-5180 (international), or click here (link will be activated 15 minutes pr.

Cushman & Wakefield continues to be awarded a Hold rating, as the stock is cheap for good reasons based on a review of its results and prospects. CWK's Q2 2024 top line missed expectations, as its services and capital markets fee revenues decreased by -2% YoY and -14% YoY, respectively. The company's updated full-year guidance was unimpressive, so it is realistic to anticipate modest earnings growth for CWK in 2024.

Cushman & Wakefield (CWK) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.22 per share a year ago.

Investors need to pay close attention to Cushman & Wakefield (CWK) stock based on the movements in the options market lately.